Using peer support and rewards to reduce methamphetamine-related harm
Official title: Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)
Funded at Oregon Health & Science University · NIH-10590236 · Data updated 2026-11-12
This study is looking at how friendly support from peers can help people using methamphetamine by offering rewards for reaching personal goals and connecting them with helpful resources, all aimed at making treatment easier and safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2022 |
| Award (this year) | $1,936,443 |
| NIH project number | 1R01DA057670-01 |
| Project ID | NIH-10590236 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use methamphetamine and are seeking harm reduction support or treatment.
✕Less likely to help
Patients who do not use methamphetamine or are not interested in harm reduction strategies may not benefit from this research.
What this research studies
This research investigates how peer recovery support specialists can help individuals using methamphetamine (MA) by providing harm reduction strategies and incentives. The study combines two effective approaches: contingency management, which rewards individuals for achieving personal harm reduction goals, and peer engagement, which connects users with supportive resources. By focusing on personalized goals, the research aims to improve treatment retention and reduce overdose risks among MA users. Participants will be engaged through a network of peer harm reduction organizations to implement these strategies effectively.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose rates and improve the overall health and well-being of individuals using methamphetamine.
How similar studies have gone: Previous research has shown that combining peer support with contingency management can effectively improve treatment outcomes for substance use disorders.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
Related research
Other NIH-funded projects on the same topics.
-
Understanding how a protein affects nerve cell movement in Alzheimer's disease
This study is looking at how a protein called APP affects the growth and movement of nerve cells, which is important for understanding Alzheimer's disease, and it aims to find out how problems with this protein might lead to nerve cell damage.
-
Understanding how the bone marrow environment drives AML resistance
A large NIH-funded project at Oregon Health & Science University is studying how the body’s own cell surroundings help acute myeloid leukemia become resistant to treatment, with potential paths to better therapies for patients.
-
Improving Safety at Work with a Low-Resource mHealth Program in Malaysia (and beyond)
A low-cost mobile health program to improve safety culture in Malaysian workplaces, with plans to adapt the approach for U.S. workers in high-risk industries.
-
Oregon Healthy Workplace Initiative for Better Health
A multi-site effort aims to improve the health and safety of workers by coordinating research, tools, and interventions across workplaces.
-
Understanding how AML cells become resistant to therapy over time
This project looks at why acute myeloid leukemia stops responding to treatment and how to design better drug combinations to prevent relapse.
-
Mechanisms and Countermeasures for Ultra-Potent Synthetic Opioid Overdose
A small, focused NIH grant aims to understand why ultra-potent synthetic opioids cause severe overdose and to explore potential countermeasures to keep people safe.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.